Inhibrx, Inc.
NASDAQ:INBX
11.47 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.2 | 1.8 | 2.178 | 7.125 | 12.808 | 9.093 | 7.5 | 7.95 | 6.667 |
| Cost of Revenue
| 0 | 1.191 | 2.846 | 2.688 | 73.495 | 47.907 | 33.454 | 25.51 | 16.992 |
| Gross Profit
| 0.2 | 0.609 | -0.668 | 4.437 | -60.687 | -38.814 | -25.954 | -17.56 | -10.325 |
| Gross Profit Ratio
| 1 | 0.338 | -0.307 | 0.623 | -4.738 | -4.269 | -3.461 | -2.209 | -1.549 |
| Reseach & Development Expenses
| 203.743 | 190.648 | 110.186 | 71.44 | 73.495 | 47.907 | 33.454 | 25.51 | 16.992 |
| General & Administrative Expenses
| 127.905 | 29.381 | 21.123 | 12.355 | 6.836 | 9.018 | 4.654 | 2.609 | 1.821 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.253 |
| SG&A
| 127.905 | 29.381 | 21.123 | 12.355 | 6.836 | 9.018 | 4.654 | 2.609 | 1.568 |
| Other Expenses
| 0 | 0 | -0.014 | -0.106 | -0.08 | -4.118 | 0.068 | 0.024 | 0 |
| Operating Expenses
| 331.648 | 219.83 | 131.295 | 83.689 | 80.251 | 52.807 | 37.013 | 27.678 | 18.56 |
| Operating Income
| -331.448 | -219.221 | -129.117 | -76.564 | -67.443 | -43.714 | -29.513 | -19.728 | -12.146 |
| Operating Income Ratio
| -1,657.24 | -121.789 | -59.282 | -10.746 | -5.266 | -4.807 | -3.935 | -2.482 | -1.822 |
| Total Other Income Expenses Net
| 2,019.022 | -20.503 | -29.9 | -5.202 | -8.191 | -6.788 | -1.412 | -2.102 | -0.739 |
| Income Before Tax
| 1,687.574 | -239.724 | -145.223 | -81.766 | -75.634 | -50.502 | -30.925 | -21.83 | -12.885 |
| Income Before Tax Ratio
| 8,437.87 | -133.18 | -66.677 | -11.476 | -5.905 | -5.554 | -4.123 | -2.746 | -1.933 |
| Income Tax Expense
| 0.002 | 0.003 | 0.003 | 0.002 | 0.003 | 0.898 | 0.096 | 0.25 | -4.616 |
| Net Income
| 1,687.572 | -241.361 | -145.226 | -81.768 | -75.637 | -51.4 | -31.163 | -19.442 | -8.269 |
| Net Income Ratio
| 8,437.86 | -134.089 | -66.679 | -11.476 | -5.905 | -5.653 | -4.155 | -2.446 | -1.24 |
| EPS
| 114.01 | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| EPS Diluted
| 112.62 | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| EBITDA
| 1,703.35 | -206.693 | -125.817 | -76.564 | -67.443 | -42.604 | -28.769 | -19.305 | -11.893 |
| EBITDA Ratio
| 8,516.75 | -114.829 | -57.767 | -10.746 | -5.266 | -4.685 | -3.836 | -2.428 | -1.784 |